TSLA
PLTR
HIMS
SPCX
SOFI
BTCBoard reshuffle, DEF 14A filed, options market signal
HIMS is speeding up its shift from telehealth to a consumer health brand and is adding top marketing talent to its board. Ahead of the Q1 results (11 May), the shares are under pressure from the Amazon GLP-1 competition narrative, but bearish sentiment in the options market has not worsened further.
Board changes
- Board size
Down from 10 members to 9
- Departures
Christiane Pendarvis and Dr Pat Carroll are not standing for re-election. Dr Carroll remains Global Chief Medical Officer.
- Investment signal
Bringing in top consumer-marketing talent suggests management is preparing to scale the brand. The DoorDash experience is especially relevant (a high-frequency, brand-trust sector).
- New nominee
Kofi Amoo-Gottfried: former chief marketing officer of DoorDash, former Meta marketing executive and a veteran of Leo Burnett and Wieden+Kennedy. He is currently a director of Stitch Fix and Vital Farms.
- Vote
Vote at the shareholder meeting in June 2026
DEF 14A proxy statement
- AGM date
To be held online on 11 Jun 2026
- Filing
The 2026 annual proxy statement (DEF 14A) has been formally filed
- Proposals
Elect 9 directors, approve KPMG as auditor and hold an advisory vote on executive pay
- 2025 revenue
$2.35 billion, up 59% year on year
Options market
- Implied move
A 50% probability of a move of more than 12.42%
- Q1 earnings date
11 May 2026
- Skew
Put-call skew is flattening, suggesting bearish sentiment has not worsened further
Price action
- Close
$27.93 (-4.95%)
- Headwind
The competition narrative around Amazon's GLP-1 entry continues to weigh on the shares
- Trend
Second straight daily pullback
Sources 1
- HIMS announcements, DEF 14A filing, options market data
A brief is a lead for our research, not a verified conclusion or advice.